METROPOLITAN LIFE INSURANCE CO/NY - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 80 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$334,153
+12.1%
5,066
-12.1%
0.02%
+30.8%
Q4 2022$298,005
-22.5%
5,763
+2.3%
0.01%
-31.6%
Q3 2022$384,666
+55.2%
5,632
+2.7%
0.02%
+72.7%
Q2 2022$247,896
-0.3%
5,482
+12.0%
0.01%
+22.2%
Q1 2022$248,664
-71.4%
4,894
-73.4%
0.01%
-25.0%
Q4 2021$870,236
+49.5%
18,406
+4.2%
0.01%
+50.0%
Q3 2021$581,975
-47.0%
17,657
+1.7%
0.01%
-46.7%
Q2 2021$1,097,531
+57.0%
17,366
+6.6%
0.02%
+50.0%
Q1 2021$699,133
-28.7%
16,293
-5.0%
0.01%
-33.3%
Q4 2020$981,152
+77.3%
17,153
-6.5%
0.02%
+50.0%
Q3 2020$553,318
-7.6%
18,3400.0%0.01%
-9.1%
Q2 2020$598,984
+22.8%
18,340
+0.7%
0.01%
+10.0%
Q1 2020$487,739
-1.2%
18,206
+12.9%
0.01%
+25.0%
Q4 2019$493,901
+27.1%
16,1300.0%0.01%
+14.3%
Q3 2019$388,572
+17.4%
16,130
+23.5%
0.01%
+16.7%
Q2 2019$330,915
+38.9%
13,059
+6.9%
0.01%
+50.0%
Q1 2019$238,212
+47.8%
12,2160.0%0.00%
+33.3%
Q4 2018$161,129
-25.8%
12,2160.0%0.00%
-25.0%
Q3 2018$217,200
-99.8%
12,216
+203.9%
0.00%
+300.0%
Q1 2018$88,882,0004,0200.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
venBio Partners LLC 1,526,122$29,759,00024.10%
Cormorant Asset Management, LP 3,600,000$70,200,0004.74%
SECTORAL ASSET MANAGEMENT INC 1,727,829$33,693,0004.05%
Hillhouse Capital Management 2,098,581$40,922,0001.71%
HHLR ADVISORS, LTD. 2,579,708$50,304,0001.40%
CLOUGH CAPITAL PARTNERS L P 589,734$11,500,0001.01%
Vivo Capital, LLC 383,538$7,479,0000.75%
Opaleye Management Inc. 115,000$2,243,0000.62%
Virtus ETF Advisers LLC 14,338$280,0000.60%
Eversept Partners, LP 104,349$2,034,8060.59%
View complete list of APELLIS PHARMACEUTICALS INC shareholders